Pharmaceutical Commerce - June 2023

Click the title above for a link to open the Pharmaceutical Commerce June 2023 issue in an interactive PDF format.

The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market.

As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.

A trip to Eastern France for LogiPharma Europe 2023.

The latest on its implementation—and the implications for biopharma.

The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.

New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.

While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.

The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.

How temperature-controlled containers can play key role in the industry's mission for carbon neutrality across the supply chain.

How pharma can harness digitalization all the way through commercialization

How maximizing the intelligence gained from brand engagement compliance activities can help drive pharmaceutical company commercial decisions.